AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Sep 25, 2019
34491_dirs_2019-09-25_d128dc70-93aa-48ba-ae37-8b889b70206e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-09-23
Reporting Person: THOMSON DAVID S. (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-09-23 | Employee Stock Option (Right to Buy) | $9.46 | A | 30922 | Acquired | 2029-09-22 | Common Stock (30922) | Direct |
Footnotes
F1: The option vests as to 25% of the underlying shares on April 1, 2020 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19